Coronary Artery Disease Clinical Trials in Philadelphia, Pennsylvania

6 studies are recruiting for coronary artery disease in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Philadelphia, Pennsylvania

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

   The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   19 in total

   Run by

   Supira Medical

   See if you can join NCT07296744 on ClinicalTrials.gov

3. Virtue® SAB in the Treatment of Coronary ISR Trial

   A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Locations

   15 in total

   Run by

   Orchestra BioMed, Inc

   See if you can join NCT07045194 on ClinicalTrials.gov

4. CTSN Embolic Protection Trial

   This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

   Stage

   Not phased

   Ages

   60 and older

   Site

   Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   28 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06027788 on ClinicalTrials.gov

5. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   51 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

6. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov